Luteolin prevents uric acid-induced pancreatic β-cell dysfunction

Journal of Biomedical Research

Volumn 28, Issue 4, 2014, Pages 292-298

  Ding, Ying ^a   Shi, Xuhui ^a   Shuai, Xuanyu ^a   Xu, Yuemei ^a   Liu, Yun ^a   Liang, Xiubin ^a   Wei, Dong ^c   Su, Dongming ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Second People's Hospital of Chengdu   (China)

Author keywords

Luteolin; MafA; Nitric oxide; Nuclear factor (NF) B; Uric acid

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUTEOLIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR MAFA; URIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ASSAY; CELL DAMAGE; CELL ISOLATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; GRIESS METHOD; HYPERURICEMIA; INSULIN RELEASE; INVESTIGATIVE PROCEDURES; MALE; MIN6 CELL LINE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING;

EID: 84923777887     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.28.20130170     Document Type: Article

References (25)

1. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009;32:1737-42.
2. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-2.
3. Krishnan E, Pandya BJ, Chung L, Hariri A. Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 2012;176:108-16.
4. Abreu E, Fonseca MJ, Santos AC. Association between hyperuricemia and insulin resistance. Acta Med Port 2011;24 Suppl 2:565-74.
5. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. Failure of beta-cell function to compensate lack of insulin action in hyperuricemic subjects. Diabetes Metab Res Rev 2009;25:535-41.
6. Jia L, Xing J, Ding Y, Shen YC, Shi XH, Ren W, et al. Hyperuricemia causes pancreatic b-cell death and dysfunction through NF-kB signaling pathway. PLoS One 2013;8(10):e78284.
7. Lin Y, Shi R, Wang X, Shen HM. Luteolin, a flavonoid with potentials for cancer prevention and therapy. Curr Cancer Drug Targets 2008;8:634-46.
8. Zhao G, Yao-Yue C, Qin GW, Guo LH. Luteolin from Purple Perilla mitigates ROS insult particularly in primary neurons. Neurobiol Aging 2012;33:176-86.
9. Song Y, Manson JE, Buring JE, Sesso HD, Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and crosssectional analysis. J Am Coll Nutr 2005;24:376-84.
10. Batumalaie K, Qvist R, Yusof KM, Ismail IS, Sekaran SD. The antioxidant effect of the Malaysian Gelam honey on pancreatic hamster cells cultured under hyperglycemic conditions. Clin Exp Med 2013. [Epub ahead of print]
11. Kim EK, Kwon KB, Song MY, Han MJ, Lee JH, Lee YR, et al. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation. Pancreas 2007;35(4):e1-9
12. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007;293:C584-96.
13. Su D, Zhang N, He J, Qu S, Slusher S, Bottino R, et al. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 2007;56:2274-83.
14. Hedeskov CJ, Capito K. The pentose cycle and insulin release in isolated mouse pancreatic islets during starvation. Biochem J 1975;152:571-6.
15. Zhang HJ, Walseth TF, Robertson RP. Insulin secretion and cAMP metabolism in HIT cells. Reciprocal and serial passage-dependent relationships. Diabetes 1989;38:44-8.
16. Zhang X, Yong W, Lv J, Zhu Y, Zhang J, Chen F, et al. Inhibition of forkhead box O1 protects pancreatic betacells against dexamethasone-induced dysfunction. Endocrinology 2009;150:4065-73.
17. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J Leukoc Biol 2010;88:1157-62.
18. Naamane N, van Helden J, Eizirik DL. In silico identification of NF-kappaB-regulated genes in pancreatic betacells. BMC Bioinformatics 2007;8:55.
19. Wang H, Brun T, Kataoka K, Sharma AJ, Wollheim CB. MAFA controls genes implicated in insulin biosynthesis and secretion. Diabetologia 2007;50:348-58.
20. Yang Z, Xiaohua W, Lei J, Ruoyun T, Mingxia X, Weichun H, et al. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells. Am J Physiol Renal Physiol 2010;299:F336-46.
21. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004;4:9.
22. Li YC, Yeh CH, Yang ML, Kuan YH. Luteol in Suppresses Inflammatory Mediator Expression by Blocking the Akt/NFkB Pathwayin Acute Lung Injury Induced by Lipopolysaccharide in Mice. Evid Based Complement Alternat Med 2012;2012:383608.
23. Chen CY, Peng WH, Tsai KD, Hsu SL. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci 2007;81:1602-14.
24. Deepa M, Sureshkumar T, Satheeshkumar PK, Priya S. Antioxidant rich Morus alba leaf extract induces apoptosis in human colon and breast cancer cells by the downregulation of nitric oxide produced by inducible nitric oxidesynthase. Nutr Cancer 2013;65:305-10.
25. Choi EY, Jin JY, Choi JI, Choi IS, Kim SJ. Effects of luteolin on the release of nitric oxide and interleukin-6 by macrophages stimulated with lipopolysaccharide from Prevotella intermedia. J Periodontol 2011;82:1509-17.